Procalcitonin: biochemistry and clinical diagnosis
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Bremen
UNI-MED Verlag
[2010]
|
| Schriftenreihe: | UNI-MED science
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben |
| Beschreibung: | 125 Seiten Diagramme 25 cm |
| ISBN: | 9783837412413 9781848151635 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047374617 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 210716s2010 gw |||| |||| 00||| eng d | ||
| 015 | |a 11,A03 |2 dnb | ||
| 016 | 7 | |a 100940704X |2 DE-101 | |
| 020 | |a 9783837412413 |c (Bremen) Pp. : EUR 24.80 |9 978-3-8374-1241-3 | ||
| 020 | |a 9781848151635 |c (London ...) Pp. |9 978-1-84815-163-5 | ||
| 035 | |a (OCoLC)697831954 | ||
| 035 | |a (DE-599)DNB100940704X | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE | ||
| 049 | |a DE-384 | ||
| 082 | 0 | |a 616.920756 |2 22/ger | |
| 084 | |a YD 3000 |0 (DE-625)153297:12905 |2 rvk | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Meisner, Michael |d 1963- |e Verfasser |0 (DE-588)123776880 |4 aut | |
| 245 | 1 | 0 | |a Procalcitonin |b biochemistry and clinical diagnosis |c [Michael Meisner] |
| 264 | 1 | |a Bremen |b UNI-MED Verlag |c [2010] | |
| 300 | |a 125 Seiten |b Diagramme |c 25 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a UNI-MED science | |
| 500 | |a Literaturangaben | ||
| 650 | 0 | 7 | |a Bakterielle Infektion |0 (DE-588)4004301-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Differentialdiagnose |0 (DE-588)4113309-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Procalcitonin |0 (DE-588)4586061-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Sepsis |0 (DE-588)4181014-4 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Bakterielle Infektion |0 (DE-588)4004301-0 |D s |
| 689 | 0 | 1 | |a Sepsis |0 (DE-588)4181014-4 |D s |
| 689 | 0 | 2 | |a Procalcitonin |0 (DE-588)4586061-0 |D s |
| 689 | 0 | 3 | |a Differentialdiagnose |0 (DE-588)4113309-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032776347&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032776347 | ||
Datensatz im Suchindex
| _version_ | 1804182615692935168 |
|---|---|
| adam_text | IMAGE 1
CONTENTS
CONTENTS
BASIC INFORMATION 9
1.1. PROCALCITONIN, A MARKER PROTEIN FOR INFECTION AND SEPSIS 9
1.2. PROPERTIES OF PCT 10
1.3. DIAGNOSIS OF SEVERE BACTERIAL INFECTIONS AND SEPSIS 10
1.4. PCT AND SEVERITY OF DISEASE 10
1.5. NON-BACTERIAL CAUSES OF ELEVATED PCT LEVELS 12
1.6. PROGNOSTIC SIGNIFICANCE AND EVALUATION OF THE PROGRESSION OF SEPSIS
12
1.7. INFLUENCE ON DIAGNOSTIC AND THERAPEUTIC DECISIONS DURING THE
CLINICAL VISIT 14
1.8. INDICATION AND MONITORING OF ANTIBIOTIC THERAPY 15
1.9. STABILITY AND KINETICS OF PCT 15
1.10. AN OVERVIEW OF BIOCHEMICAL PROPERTIES 16
PRIMARY INDICATIONS 17
2.1. DIAGNOSIS, PROGRESSION EVALUATION, AND THERAPY OF BACTERIAL
INFECTIONS AND SEPSIS 17 2.1.1. DIAGNOSIS OF SEPSIS, SEVERE SEPSIS, AND
SEPTIC SHOCK 17
2.1.2. DIFFERENTIAL DIAGNOSIS OF SEVERE BACTERIAL INFECTION AND SEPSIS
19
2.1.3. EVALUATION OF THE SEVERITY OF SEPSIS AND THE SYSTEMIC
INFLAMMATORY REACTION 22 2.1.4. PROGRESSION AND PROGNOSTIC SIGNIFICANCE
23
2.1.5. INDICATION AND CONTROL OF ANTIBIOTIC TREATMENT 25
2.2. PCT LEVEL MEASUREMENT IN SPECIFIC CLINICAL AREAS 26
2.2.1. PCT IN THE INTENSIVE CARE UNIT 26
2.2.2. PCT IN THE EMERGENCY ROOM 27
2.2.3. PCT IN OUTPATIENT CASES 30
BIOCHEMISTRY, PATHOPHYSIOLOGY 33
3.1. PROCALCITONIN (PCT), A SOLUBLE PROTEIN 33
3.2. GENETICS 34
3.3. MECHANISMS OF INDUCTION AND ELIMINATION OF PCT 35
3.4. TIME BEHAVIOR OF INDUCTION AND ELIMINATION 36
3.5. BIOLOGICAL EFFECTS OF PCT 36
LABORATORY CHEMISTRY 39
4.1. METHODS OF PCT LEVEL MEASUREMENT 39
4.2. STABILITY AND HALF-LIFE IN VITRO, PREANALYTICAL FACTORS 39
4.3. NORMAL VALUES AND REFERENCE RANGES OF PCT 39
PCT AS A MARKER OF INFECTION AND SEPSIS: AN EVIDENCE-BASED COLLECTION OF
DATA 40
5.1. DIFFERENTIAL DIAGNOSIS OF BACTERIAL INFECTIONS: SIRS AND SEPSIS 40
5.2. PCT AS A MARKER OF THE PROGRESSION OF INFECTION TO SEPSIS, SEVERE
SEPSIS AND SEPTIC SHOCK ... 45
5.3. INTERPRETATION OF PCT IN THE CLINICAL CONTEXT 46
5.4. PCT: A MARKER OF INFECTION OR OF INFLAMMATION? 46
5.5. COMPARISON WITH OTHER MARKERS 48
BIBLIOGRAFISCHE INFORMATIONEN HTTP://D-NB.INFO/100940704X
DIGITALISIERT DURCH
IMAGE 2
G CONTENTS
USE OF PCT FOR THE CONTROL OF ANTIBIOTIC THERAPY 52
6.1. BASICS OF AN INDIVIDUAL, PATIENT-ADAPTED ANTIBIOTIC TREATMENT USING
PCT 52
6.2. PCT-CONTROLLED ANTIBIOTIC THERAPY IN AIRWAY INFECTIONS 57
6.2.1. OVERVIEW OF CURRENT STUDIES 57
6.2.2. PATIENTS WITH SUSPICION OF INFECTIONS OF THE UPPER AIRWAYS IN THE
EMERGENCY ROOM: THE PRORESP STUDY 58
6.2.3. PCT, ANTIBIOTIC THERAPY, AND EXACERBATION OF COPD: THE PROCOLD
STUDY 59 6.2.4. OUTPATIENTS WITH SUSPICION OF AIRWAY INFECTIONS: THE
PARTI STUDY 60
6.2.5. INDIVIDUAL, PATIENT-ADAPTED TREATMENT OF COMMUNITY-ACQUIRED
PNEUMONIA WITH PCT:
THE PROCAP STUDY 60
6.3. CONTROL OF ANTIBIOTIC TREATMENT IN PATIENTS IN INTENSIVE CARE WITH
SEPSIS, SEVERE SEPSIS AND SEPTIC SHOCK 62
USE FOR SPECIAL INDICATIONS 65
7.1. DIAGNOSTIC USE OF PCT IN PATIENTS WITH PNEUMONIA 65
7.2. BACTEREMIA 67
7.3. BACTERIAL ENDOCARDITIS 68
7.4. ACUTE BACTERIAL MENINGITIS 69
7.5. DIFFERENTIAL DIAGNOSIS OF VIRAL DISEASES 71
7.6. FUNGAL DISEASES: ASPERGILLUS AND CANDIDA INFECTIONS 72
7.7. AUTOIMMUNE DISEASES 73
7.8. ALLERGIC DISEASES 74
7.9. PANCREATITIS 74
7.10. VESICOURETHRAL REFLUX, PYELONEPHRITIS, AND URINARY TRACT
INFECTIONS 76
EXCEPTIONS AND SPECIAL CASES 79
8.1. PCT INDUCTION WITHOUT INDICATION OF A BACTERIAL FOCUS 79
8.2. INDUCTION OF PCT AFTER SURGICAL INTERVENTIONS AND TRAUMA 81
8.3. PCT AFTER ORGAN TRANSPLANTATION 85
8.4. PCT IN RENAL INSUFFICIENCY 86
8.5. TUMOR ILLNESSES 87
8.6. HEMATOLOGICAL/ONCOLOGICAL ILLNESSES, CHEMOTHERAPY 88
8.7. PCT IN PATIENTS WITH LEUKOPENIA 90
8.8. BONE MARROW TRANSPLANTATION AND TRANSPLANTATION OF HEMATOPOETIC
STEM CELLS 91
CHILDREN AND NEWBORNS 92
9.1. MEASURING PCT LEVELS IN CHILDREN 92
9.2. THE FIRST DAYS AFTER BIRTH: DIAGNOSING NEWBORN SEPSIS 93
9.3. INFANTS ( 3 DAYS), TODDLERS AND CHILDREN 97
FREQUENTLY ASKED QUESTIONS 103
LITERATURE 1 06
INDEX -J23
|
| adam_txt |
IMAGE 1
CONTENTS
CONTENTS
BASIC INFORMATION 9
1.1. PROCALCITONIN, A MARKER PROTEIN FOR INFECTION AND SEPSIS 9
1.2. PROPERTIES OF PCT 10
1.3. DIAGNOSIS OF SEVERE BACTERIAL INFECTIONS AND SEPSIS 10
1.4. PCT AND SEVERITY OF DISEASE 10
1.5. NON-BACTERIAL CAUSES OF ELEVATED PCT LEVELS 12
1.6. PROGNOSTIC SIGNIFICANCE AND EVALUATION OF THE PROGRESSION OF SEPSIS
12
1.7. INFLUENCE ON DIAGNOSTIC AND THERAPEUTIC DECISIONS DURING THE
CLINICAL VISIT 14
1.8. INDICATION AND MONITORING OF ANTIBIOTIC THERAPY 15
1.9. STABILITY AND KINETICS OF PCT 15
1.10. AN OVERVIEW OF BIOCHEMICAL PROPERTIES 16
PRIMARY INDICATIONS 17
2.1. DIAGNOSIS, PROGRESSION EVALUATION, AND THERAPY OF BACTERIAL
INFECTIONS AND SEPSIS 17 2.1.1. DIAGNOSIS OF SEPSIS, SEVERE SEPSIS, AND
SEPTIC SHOCK 17
2.1.2. DIFFERENTIAL DIAGNOSIS OF SEVERE BACTERIAL INFECTION AND SEPSIS
19
2.1.3. EVALUATION OF THE SEVERITY OF SEPSIS AND THE SYSTEMIC
INFLAMMATORY REACTION 22 2.1.4. PROGRESSION AND PROGNOSTIC SIGNIFICANCE
23
2.1.5. INDICATION AND CONTROL OF ANTIBIOTIC TREATMENT 25
2.2. PCT LEVEL MEASUREMENT IN SPECIFIC CLINICAL AREAS 26
2.2.1. PCT IN THE INTENSIVE CARE UNIT 26
2.2.2. PCT IN THE EMERGENCY ROOM 27
2.2.3. PCT IN OUTPATIENT CASES 30
BIOCHEMISTRY, PATHOPHYSIOLOGY 33
3.1. PROCALCITONIN (PCT), A SOLUBLE PROTEIN 33
3.2. GENETICS 34
3.3. MECHANISMS OF INDUCTION AND ELIMINATION OF PCT 35
3.4. TIME BEHAVIOR OF INDUCTION AND ELIMINATION 36
3.5. BIOLOGICAL EFFECTS OF PCT 36
LABORATORY CHEMISTRY 39
4.1. METHODS OF PCT LEVEL MEASUREMENT 39
4.2. STABILITY AND HALF-LIFE IN VITRO, PREANALYTICAL FACTORS 39
4.3. NORMAL VALUES AND REFERENCE RANGES OF PCT 39
PCT AS A MARKER OF INFECTION AND SEPSIS: AN EVIDENCE-BASED COLLECTION OF
DATA 40
5.1. DIFFERENTIAL DIAGNOSIS OF BACTERIAL INFECTIONS: SIRS AND SEPSIS 40
5.2. PCT AS A MARKER OF THE PROGRESSION OF INFECTION TO SEPSIS, SEVERE
SEPSIS AND SEPTIC SHOCK . 45
5.3. INTERPRETATION OF PCT IN THE CLINICAL CONTEXT 46
5.4. PCT: A MARKER OF INFECTION OR OF INFLAMMATION? 46
5.5. COMPARISON WITH OTHER MARKERS 48
BIBLIOGRAFISCHE INFORMATIONEN HTTP://D-NB.INFO/100940704X
DIGITALISIERT DURCH
IMAGE 2
G CONTENTS
USE OF PCT FOR THE CONTROL OF ANTIBIOTIC THERAPY 52
6.1. BASICS OF AN INDIVIDUAL, PATIENT-ADAPTED ANTIBIOTIC TREATMENT USING
PCT 52
6.2. PCT-CONTROLLED ANTIBIOTIC THERAPY IN AIRWAY INFECTIONS 57
6.2.1. OVERVIEW OF CURRENT STUDIES 57
6.2.2. PATIENTS WITH SUSPICION OF INFECTIONS OF THE UPPER AIRWAYS IN THE
EMERGENCY ROOM: THE "PRORESP" STUDY 58
6.2.3. PCT, ANTIBIOTIC THERAPY, AND EXACERBATION OF COPD: THE "PROCOLD"
STUDY 59 6.2.4. OUTPATIENTS WITH SUSPICION OF AIRWAY INFECTIONS: THE
"PARTI" STUDY 60
6.2.5. INDIVIDUAL, PATIENT-ADAPTED TREATMENT OF COMMUNITY-ACQUIRED
PNEUMONIA WITH PCT:
THE "PROCAP" STUDY 60
6.3. CONTROL OF ANTIBIOTIC TREATMENT IN PATIENTS IN INTENSIVE CARE WITH
SEPSIS, SEVERE SEPSIS AND SEPTIC SHOCK 62
USE FOR SPECIAL INDICATIONS 65
7.1. DIAGNOSTIC USE OF PCT IN PATIENTS WITH PNEUMONIA 65
7.2. BACTEREMIA 67
7.3. BACTERIAL ENDOCARDITIS 68
7.4. ACUTE BACTERIAL MENINGITIS 69
7.5. DIFFERENTIAL DIAGNOSIS OF VIRAL DISEASES 71
7.6. FUNGAL DISEASES: ASPERGILLUS AND CANDIDA INFECTIONS 72
7.7. AUTOIMMUNE DISEASES 73
7.8. ALLERGIC DISEASES 74
7.9. PANCREATITIS 74
7.10. VESICOURETHRAL REFLUX, PYELONEPHRITIS, AND URINARY TRACT
INFECTIONS 76
EXCEPTIONS AND SPECIAL CASES 79
8.1. PCT INDUCTION WITHOUT INDICATION OF A BACTERIAL FOCUS 79
8.2. INDUCTION OF PCT AFTER SURGICAL INTERVENTIONS AND TRAUMA 81
8.3. PCT AFTER ORGAN TRANSPLANTATION 85
8.4. PCT IN RENAL INSUFFICIENCY 86
8.5. TUMOR ILLNESSES 87
8.6. HEMATOLOGICAL/ONCOLOGICAL ILLNESSES, CHEMOTHERAPY 88
8.7. PCT IN PATIENTS WITH LEUKOPENIA 90
8.8. BONE MARROW TRANSPLANTATION AND TRANSPLANTATION OF HEMATOPOETIC
STEM CELLS 91
CHILDREN AND NEWBORNS 92
9.1. MEASURING PCT LEVELS IN CHILDREN 92
9.2. THE FIRST DAYS AFTER BIRTH: DIAGNOSING NEWBORN SEPSIS 93
9.3. INFANTS ( 3 DAYS), TODDLERS AND CHILDREN 97
FREQUENTLY ASKED QUESTIONS 103
LITERATURE 1 06
INDEX -J23 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Meisner, Michael 1963- |
| author_GND | (DE-588)123776880 |
| author_facet | Meisner, Michael 1963- |
| author_role | aut |
| author_sort | Meisner, Michael 1963- |
| author_variant | m m mm |
| building | Verbundindex |
| bvnumber | BV047374617 |
| classification_rvk | YD 3000 |
| ctrlnum | (OCoLC)697831954 (DE-599)DNB100940704X |
| dewey-full | 616.920756 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.920756 |
| dewey-search | 616.920756 |
| dewey-sort | 3616.920756 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01865nam a2200481 c 4500</leader><controlfield tag="001">BV047374617</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210716s2010 gw |||| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">11,A03</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">100940704X</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783837412413</subfield><subfield code="c">(Bremen) Pp. : EUR 24.80</subfield><subfield code="9">978-3-8374-1241-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781848151635</subfield><subfield code="c">(London ...) Pp.</subfield><subfield code="9">978-1-84815-163-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)697831954</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB100940704X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.920756</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YD 3000</subfield><subfield code="0">(DE-625)153297:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Meisner, Michael</subfield><subfield code="d">1963-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)123776880</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Procalcitonin</subfield><subfield code="b">biochemistry and clinical diagnosis</subfield><subfield code="c">[Michael Meisner]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bremen</subfield><subfield code="b">UNI-MED Verlag</subfield><subfield code="c">[2010]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">125 Seiten</subfield><subfield code="b">Diagramme</subfield><subfield code="c">25 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">UNI-MED science</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bakterielle Infektion</subfield><subfield code="0">(DE-588)4004301-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Differentialdiagnose</subfield><subfield code="0">(DE-588)4113309-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Procalcitonin</subfield><subfield code="0">(DE-588)4586061-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sepsis</subfield><subfield code="0">(DE-588)4181014-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Bakterielle Infektion</subfield><subfield code="0">(DE-588)4004301-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Sepsis</subfield><subfield code="0">(DE-588)4181014-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Procalcitonin</subfield><subfield code="0">(DE-588)4586061-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Differentialdiagnose</subfield><subfield code="0">(DE-588)4113309-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032776347&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032776347</subfield></datafield></record></collection> |
| id | DE-604.BV047374617 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T17:45:56Z |
| indexdate | 2024-07-10T09:10:22Z |
| institution | BVB |
| isbn | 9783837412413 9781848151635 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032776347 |
| oclc_num | 697831954 |
| open_access_boolean | |
| owner | DE-384 |
| owner_facet | DE-384 |
| physical | 125 Seiten Diagramme 25 cm |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | UNI-MED Verlag |
| record_format | marc |
| series2 | UNI-MED science |
| spelling | Meisner, Michael 1963- Verfasser (DE-588)123776880 aut Procalcitonin biochemistry and clinical diagnosis [Michael Meisner] Bremen UNI-MED Verlag [2010] 125 Seiten Diagramme 25 cm txt rdacontent n rdamedia nc rdacarrier UNI-MED science Literaturangaben Bakterielle Infektion (DE-588)4004301-0 gnd rswk-swf Differentialdiagnose (DE-588)4113309-2 gnd rswk-swf Procalcitonin (DE-588)4586061-0 gnd rswk-swf Sepsis (DE-588)4181014-4 gnd rswk-swf Bakterielle Infektion (DE-588)4004301-0 s Sepsis (DE-588)4181014-4 s Procalcitonin (DE-588)4586061-0 s Differentialdiagnose (DE-588)4113309-2 s DE-604 DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032776347&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Meisner, Michael 1963- Procalcitonin biochemistry and clinical diagnosis Bakterielle Infektion (DE-588)4004301-0 gnd Differentialdiagnose (DE-588)4113309-2 gnd Procalcitonin (DE-588)4586061-0 gnd Sepsis (DE-588)4181014-4 gnd |
| subject_GND | (DE-588)4004301-0 (DE-588)4113309-2 (DE-588)4586061-0 (DE-588)4181014-4 |
| title | Procalcitonin biochemistry and clinical diagnosis |
| title_auth | Procalcitonin biochemistry and clinical diagnosis |
| title_exact_search | Procalcitonin biochemistry and clinical diagnosis |
| title_exact_search_txtP | Procalcitonin biochemistry and clinical diagnosis |
| title_full | Procalcitonin biochemistry and clinical diagnosis [Michael Meisner] |
| title_fullStr | Procalcitonin biochemistry and clinical diagnosis [Michael Meisner] |
| title_full_unstemmed | Procalcitonin biochemistry and clinical diagnosis [Michael Meisner] |
| title_short | Procalcitonin |
| title_sort | procalcitonin biochemistry and clinical diagnosis |
| title_sub | biochemistry and clinical diagnosis |
| topic | Bakterielle Infektion (DE-588)4004301-0 gnd Differentialdiagnose (DE-588)4113309-2 gnd Procalcitonin (DE-588)4586061-0 gnd Sepsis (DE-588)4181014-4 gnd |
| topic_facet | Bakterielle Infektion Differentialdiagnose Procalcitonin Sepsis |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032776347&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT meisnermichael procalcitoninbiochemistryandclinicaldiagnosis |